<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-22261" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Acute Angle-Closure Glaucoma</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Khazaeni</surname>
            <given-names>Babak</given-names>
          </name>
          <aff>Desert Regional Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Zeppieri</surname>
            <given-names>Marco</given-names>
          </name>
          <aff>University Hospital of Udine, Italy</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Khazaeni</surname>
            <given-names>Leila</given-names>
          </name>
          <aff>Loma Linda University</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Babak Khazaeni declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Marco Zeppieri declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Leila Khazaeni declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>26</day>
          <month>11</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-22261.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Acute angle-closure glaucoma is an ocular emergency that results from a rapid increase in intraocular pressure due to outflow obstruction of aqueous humor. Several factors lead to the obstruction in acute angle-closure glaucoma, but the major predisposing factor is the structural anatomy of the anterior chamber, leading to a shallower angle between the iris and the cornea. Acute angle-closure glaucoma presents as a sudden onset of severe unilateral eye pain or a headache associated with blurred vision, rainbow-colored halos around bright lights, nausea, and vomiting. This activity reviews the evaluation and&#x000a0;treatment of patients with acute angle-closure glaucoma and highlights the role of the interprofessional team in managing patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify patients at risk of acute closed-angle glaucoma through comprehensive medical history, ocular examination, and relevant diagnostic tests.</p></list-item><list-item><p>Assess the severity and progression of acute closed-angle glaucoma using appropriate clinical and imaging modalities.</p></list-item><list-item><p>Select and utilize appropriate pharmacological agents and procedures to manage acute closed-angle glaucoma.</p></list-item><list-item><p>Collaborate with other healthcare professionals, such as ophthalmologists and optometrists, in managing and following up on patients with acute closed-angle glaucoma.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=22261&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=22261">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-22261.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Glaucoma, characterized by increased intraocular pressures (IOP), can result in optic neuropathy and vision loss if left untreated.<xref ref-type="bibr" rid="article-22261.r1">[1]</xref>&#x000a0;It&#x000a0;is&#x000a0;classified as open-angle or closed-angle and can be primary or secondary depending on the obstruction in the anterior chamber. The angle refers to the space between the iris and the cornea in the anterior chamber, which can become structurally obstructed.</p>
        <p>Primary glaucomas are not associated with known ocular or systemic disorders and usually affect both eyes. In contrast, secondary glaucomas are often unilateral and linked&#x000a0;to ocular or systemic diseases. Acute closed-angle glaucoma (ACAG) is a subset of primary angle-closure glaucoma. Acute angle-closure (AAC) is an ophthalmologic emergency with elevated IOP, posing a risk of&#x000a0;irreversible damage and&#x000a0;potential blindness not treated promptly.<xref ref-type="bibr" rid="article-22261.r2">[2]</xref>&#x000a0;</p>
        <p>AAC usually presents with significant and distressing symptoms such as unilateral intense periocular pain, redness in the eye, rapid vision loss,&#x000a0;systemic&#x000a0;symptoms, nausea, headache, multicolored halos around light sources, and vomiting.<xref ref-type="bibr" rid="article-22261.r3">[3]</xref>&#x000a0;Nonophthalmologic&#x000a0;practitioners may misinterpret these symptoms as neurological conditions, leading to unnecessary cranial imaging and neurologic&#x000a0;consultations before&#x000a0;ophthalmologic examinations are conducted.<xref ref-type="bibr" rid="article-22261.r4">[4]</xref></p>
        <p>The diagnosis of AAC is confirmed by&#x000a0;elevated IOP measured using tonometry, which can range from 50 to 80 mm Hg.<xref ref-type="bibr" rid="article-22261.r5">[5]</xref>&#x000a0;Examination with a slit-lamp microscope usually&#x000a0;reveals a shallow anterior chamber, corneal edema, fixed dilated pupil, conjunctival injection around the limbus (ciliary flush), and a closed angle on gonioscopy.<xref ref-type="bibr" rid="article-22261.r6">[6]</xref>&#x000a0;Treatment options include medical, laser, and surgical interventions to reduce IOP, relieve acute symptoms, and prevent future angle closures.<xref ref-type="bibr" rid="article-22261.r7">[7]</xref></p>
        <p>The normal range for IOP&#x000a0;measured by&#x000a0;tonometry is 10 to 21 mm Hg.<xref ref-type="bibr" rid="article-22261.r8">[8]</xref>&#x000a0;IOP is influenced by the ciliary body's production rate of aqueous humor, the resistance to aqueous outflow through the trabecular meshwork and Schlemm's canal, and the episcleral venous pressure. Aqueous humor is produced in the ciliary body, passes through the pupil, and drains through the trabecular meshwork (TM) and Schlemm canal at the anterior chamber's angle. In ACAG, IOP increases rapidly due to outflow obstruction of the aqueous humor.&#x000a0;The&#x000a0;main predisposing factor for ACAG is the anterior chamber's structural anatomy, which&#x000a0;can lead&#x000a0;to a shallower angle.<xref ref-type="bibr" rid="article-22261.r9">[9]</xref><xref ref-type="bibr" rid="article-22261.r10">[10]</xref></p>
      </sec>
      <sec id="article-22261.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Primary angle closure is&#x000a0;characterized by a&#x000a0;reversible (appositional) closure of the anterior chamber angle or an adhesional (synechial) closure.&#x000a0;It can present in&#x000a0;acute or chronic forms. Acute angle closure occurs when there is a sudden increase in IOP due to blockage of aqueous outflow from the trabecular meshwork (TM), resulting from a pupillary block of the iris that leads to complete closure of the angle.<xref ref-type="bibr" rid="article-22261.r11">[11]</xref></p>
        <p>The subacute or intermittent form of primary angle closure is characterized by recurrent symptomatic episodes that are self-limiting.<xref ref-type="bibr" rid="article-22261.r12">[12]</xref>&#x000a0;In contrast, the chronic condition involves repeated episodes of angle closure,&#x000a0;resulting in elevated IOP without symptoms and causing&#x000a0;structural damage in the angle due to prolonged contact between the trabecular meshwork and peripheral iris.<xref ref-type="bibr" rid="article-22261.r13">[13]</xref>&#x000a0;This can lead to synechial closure and both structural and functional&#x000a0;impairment&#x000a0;in the angle over time.<xref ref-type="bibr" rid="article-22261.r14">[14]</xref></p>
        <p>Aqueous humor flow obstruction in primary angle closure is attributed to various anatomic factors, including a shallow anterior chamber, lens size, anterior&#x000a0;positioning of the iris-lens diaphragm, and a narrow entrance to the anterior chamber angle.<xref ref-type="bibr" rid="article-22261.r15">[15]</xref> The shallow anterior chamber angle&#x000a0;causes extensive&#x000a0;contact between the iris and lens, impeding the flow of aqueous humor from the posterior to the anterior chamber. This&#x000a0;results in&#x000a0;a pressure difference between the chambers, known as a pupillary block.<xref ref-type="bibr" rid="article-22261.r16">[16]</xref>&#x000a0;</p>
        <p>The pupillary block&#x000a0;mechanism induces&#x000a0;bowing of the iris,&#x000a0;further&#x000a0;narrowing the angle of the anterior chamber. This ongoing cycle&#x000a0;perpetuates increasing IOP, leading to the clinical&#x000a0;manifestation of ACAG.<xref ref-type="bibr" rid="article-22261.r17">[17]</xref></p>
        <p>The American Academy of Ophthalmology guidelines classify primary angle closure based on&#x000a0;specific criteria, including&#x000a0;the presence of a narrow angle, more than 180&#x000b0; of iridotrabecular contact (ITC), presence of peripheral anterior synechiae (PAS),&#x000a0;elevated&#x000a0;IOP, and signs of optic nerve damage.<xref ref-type="bibr" rid="article-22261.r18">[18]</xref>&#x000a0;Primary angle closure suspect (PACS)&#x000a0;refers to&#x000a0;an eye with ITC but no elevated IOP or PAS. "Primary angle closure" (PAC) is&#x000a0;diagnosed when there is ITC with either PAS, IOP, or both.&#x000a0;The term "primary angle-closure glaucoma" (PACG) is used when there is evidence of a glaucomatous retinal nerve fiber layer with or without optic nerve damage.</p>
      </sec>
      <sec id="article-22261.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The number of people worldwide affected by glaucoma was reported to be&#x000a0;approximately 65 million in 2013.&#x000a0;However, incidence was estimated to&#x000a0;have increased to as high as 76 million in 2020 and is&#x000a0;projected to reach over 110 million by 2040.<xref ref-type="bibr" rid="article-22261.r19">[19]</xref>&#x000a0;Among these cases, one-third are due to PACG. Meta-analyses have consistently demonstrated that PACG is more likely to lead to blindness than primary open-angle glaucoma.<xref ref-type="bibr" rid="article-22261.r20">[20]</xref></p>
        <p>Acute angle-closure (AAC) glaucoma is considered a&#x000a0;rare occurrence. The incidence of AAC in white individuals has been reported to be approximately 2 to 4 cases per 100,000 people.<xref ref-type="bibr" rid="article-22261.r6">[6]</xref>&#x000a0;However, the incidence has been higher in certain populations, such as Singapore and Asia, ranging from 6 to 12 cases per 100,000 inhabitants.<xref ref-type="bibr" rid="article-22261.r21">[21]</xref><xref ref-type="bibr" rid="article-22261.r22">[22]</xref></p>
        <p>Identified risk factors&#x000a0;associated with ACAG include the following:<xref ref-type="bibr" rid="article-22261.r23">[23]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Age:</bold>&#x000a0;ACG tends to manifest between the ages of&#x000a0;55&#x000a0;and 65, and the condition's prevalence further increases with age. This is&#x000a0;likely&#x000a0;due to the increasing thickness of the lens with age and the decreasing depth of the&#x000a0;anterior chamber.<xref ref-type="bibr" rid="article-22261.r24">[24]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Gender</bold>: Studies have&#x000a0;indicated that&#x000a0;females have&#x000a0;a 2 to 4 times higher incidence rate of AAC than males.<xref ref-type="bibr" rid="article-22261.r22">[22]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Race</bold>: ACAG is commonly observed in Southeast Asian, Chinese, and Inuit peoples&#x000a0;while remaining relatively uncommon in black populations. The variability in ethnicities could be due to anatomical differences in the ciliary body and iris.<xref ref-type="bibr" rid="article-22261.r2">[2]</xref> In white people, ACAG accounts for 6% of all glaucoma diagnoses.<xref ref-type="bibr" rid="article-22261.r25">[25]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Family history:</bold> Predisposed ocular anatomic features at risk can be inherited.<xref ref-type="bibr" rid="article-22261.r26">[26]</xref><xref ref-type="bibr" rid="article-22261.r27">[27]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Hyperopia:</bold> Certain ocular anatomical features associated with an increased risk of ACG can be inherited. The predisposition to develop ACG can be passed down through familial lines.<xref ref-type="bibr" rid="article-22261.r28">[28]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Medications:</bold>&#x000a0;Over&#x000a0;60 drugs have been reported to be associated with AAC and are considered risk factors, particularly for individuals with ocular predispositions. These drugs include topical anticholinergic pupil dilators, such as atropine and cyclopentolate, and systemic medication, including topiramate, sulfonamides, duloxetine, and phenothiazines.<xref ref-type="bibr" rid="article-22261.r29">[29]</xref> Patients using these&#x000a0;medications should undergo regular ophthalmic examinations, especially&#x000a0;if they possess AAC risk factors.<xref ref-type="bibr" rid="article-22261.r30">[30]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-22261.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>AAC is precipitated by the blockage of aqueous outflow from the TM, resulting in a sudden and non&#x02014;self-resolving&#x000a0;increase in IOP.&#x000a0;This elevated pressure&#x000a0;leads to significant systemic and ophthalmologic signs and symptoms.</p>
        <p>Primary AAC refers to cases where the angle closure arises in isolation without any causes or associated diseases.<xref ref-type="bibr" rid="article-22261.r31">[31]</xref>&#x000a0;It occurs due to anatomical factors such as a shallow anterior chamber or a narrow angle predisposing the individual to sudden angle closure. On the other hand, secondary AAC refers to cases where angle closure is a consequence of other underlying causes&#x000a0;or diseases.<xref ref-type="bibr" rid="article-22261.r32">[32]</xref>&#x000a0;These underlying factors can include trauma, inflammation, tumors, or certain systemic conditions that affect the eye's structures or the flow of aqueous humor.</p>
        <p>The most common causes of primary AAC are attributed to a mechanism called pupillary block.<xref ref-type="bibr" rid="article-22261.r33">[33]</xref> In certain conditions like mydriasis and posterior synechiae in eyes at risk of AAC, increased apposition between the lens and iris can&#x000a0;disrupt the normal movement of&#x000a0;aqueous humor from the posterior chamber.</p>
        <p>As a result of this disruption, fluid forces are built behind the iris,&#x000a0;pushing and&#x000a0;bulging&#x000a0;the peripheral iris. This bulging&#x000a0;causes&#x000a0;the iris to come in contact with the TM, leading to the acute closure of the&#x000a0;angle between the iris and cornea.<xref ref-type="bibr" rid="article-22261.r34">[34]</xref> This mechanism obstructs aqueous humor outflow,&#x000a0;resulting in&#x000a0;an acute and abrupt rise in IOP.<xref ref-type="bibr" rid="article-22261.r35">[35]</xref>&#x000a0;</p>
        <p>Nonpupillary block mechanisms can also cause angle closure and obstruct aqueous outflow from the TM. These conditions include plateau iris syndrome, ciliary body edema, anteriorly displaced or enlarged lens, and malignant glaucoma.<xref ref-type="bibr" rid="article-22261.r36">[36]</xref></p>
      </sec>
      <sec id="article-22261.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>AAC typically presents with sudden and severe symptoms, which may include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Eye pain or headache</p>
          </list-item>
          <list-item>
            <p>Blurred vision and reduced visual acuity</p>
          </list-item>
          <list-item>
            <p>Rainbow-colored halos</p>
          </list-item>
          <list-item>
            <p>Nausea and vomiting</p>
          </list-item>
        </list>
        <p>During a physical examination, the following findings may be observed:</p>
        <list list-type="bullet">
          <list-item>
            <p>Fixed midpoint dilated pupil</p>
          </list-item>
          <list-item>
            <p>Engorged conjunctival vessels</p>
          </list-item>
          <list-item>
            <p>Hazy or cloudy cornea</p>
          </list-item>
          <list-item>
            <p>Marked conjunctival injection</p>
          </list-item>
          <list-item>
            <p>Elevated intraocular pressure: Intraocular pressure is significantly increased during an acute attack and can reach high levels, ranging from 60 to 80 mm Hg.</p>
          </list-item>
          <list-item>
            <p>Mild aqueous flare and cells: Examination of the anterior chamber may reveal a slight amount of aqueous flare (haziness) and cells, indicating inflammation.</p>
          </list-item>
          <list-item>
            <p>Angle-closure on gonioscopy: Gonioscopy will reveal angle closure for 360 degrees, confirming the diagnosis of AAC.</p>
          </list-item>
          <list-item>
            <p>Swollen optic nerve: The optic nerve may appear swollen during an acute attack, indicating optic nerve head edema.<xref ref-type="bibr" rid="article-22261.r37">[37]</xref><xref ref-type="bibr" rid="article-22261.r38">[38]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-22261.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Several diagnostic procedures are commonly performed in evaluating a patient with suspected&#x000a0;AAC and include the following:&#x000a0;</p>
        <p><bold>Slit-lamp examination:</bold> Slit-lamp examination is essential for a detailed assessment of the anterior segment of the eye. It allows for a close examination of the cornea, iris, and anterior chamber to observe any abnormalities, such as corneal edema, conjunctival injection, or an anatomically narrow angle.</p>
        <p><bold>Measurement of intraocular pressure (IOP):</bold> Elevated intraocular pressure is a hallmark of AAC. Measuring the IOP using tonometry is a critical diagnostic step. Elevated IOP levels are typically observed in AAC, and values can be markedly high during an acute attack.</p>
        <p><bold>Imaging studies:</bold> In the acute phase of AAC, imaging studies are generally unnecessary for diagnosis. The clinical signs and symptoms, along with the findings obtained from the slit-lamp examination and IOP measurement, are usually sufficient to establish a diagnosis.</p>
        <p><bold>Basic metabolic panel:</bold> If osmotic agents, such as mannitol or glycerin, are used as part of the treatment regimen, checking a basic metabolic panel can help monitor electrolyte levels and renal function due to the potential systemic effects of these agents.</p>
        <p><bold>Gonioscopic examination:</bold> A gonioscopic examination, performed by an ophthalmologist, is crucial for verifying angle closure and making a definitive diagnosis of AAC. It involves evaluating the angle between the iris and cornea to determine the extent of closure. Gonioscopy of the unaffected eye may reveal a narrow, almost occluded angle, considering the anatomic predisposing factors for angle-closure glaucoma.</p>
        <p><bold>Glaucomflecken:</bold> Glaucomflecken refers to grey-white opacities that may be visible on the anterior lens capsule, typically following previous episodes of angle-closure glaucoma. These opacities can be observed during a slit-lamp examination, providing evidence of past attacks.<xref ref-type="bibr" rid="article-22261.r39">[39]</xref></p>
        <p>Visual field testing with automated static perimetry and Optical Coherence Tomography (OCT) is crucial in managing patients with acute angle-closure glaucoma (AAC) to assess various aspects of the condition and guide treatment decisions.</p>
        <p>Visual field testing: Automated static perimetry helps evaluate the extent and severity of glaucomatous visual field loss caused by AAC. It measures the patient's ability to perceive visual stimuli at different locations within their visual field. Serial visual field testing over time can provide valuable information about the condition's progression and the treatment's effectiveness.</p>
        <p>Optical Coherence Tomography (OCT): OCT is a noninvasive imaging technique that provides detailed cross-sectional images of the retina and optic nerve head. It is useful in assessing retinal nerve fiber layer (RNFL) thickness, indicating damage caused by AAC. OCT can also help detect structural abnormalities and optic nerve head changes characteristic of glaucoma. Serial OCT scans allow for monitoring changes over time and assessing the response to treatment.</p>
        <p>Anterior segment OCT and ultrasound biomicroscopy: In patients with risk factors for AAC, such as hyperopia, shallow anterior chamber, or a history of AAC in the fellow eye, anterior segment OCT and ultrasound biomicroscopy can be helpful. These imaging modalities provide detailed visualization of the anterior segment structures, including the angle, iris, and ciliary body. They can help assess anatomical features associated with angle closure and aid in decision-making for preventive measures or further interventions.&#x000a0;</p>
      </sec>
      <sec id="article-22261.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The medical treatment&#x000a0;of acute angle-closure glaucoma&#x000a0;focuses&#x000a0;on rapidly&#x000a0;lowering IOP by blocking the production of aqueous humor, increasing the outflow of aqueous humor, and reducing the volume of aqueous humor.<xref ref-type="bibr" rid="article-22261.r18">[18]</xref><xref ref-type="bibr" rid="article-22261.r40">[40]</xref></p>
        <p>Initial medical therapy typically involves a combination of medications to reduce IOP and relieve symptoms rapidly. The following medications are commonly used:</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Oral or intravenous acetazolamide:</bold> Acetazolamide, a carbonic anhydrase inhibitor, is administered orally or intravenously to reduce aqueous humor production. It helps lower IOP by inhibiting the enzyme responsible for forming bicarbonate ions, reducing the aqueous humor secretion.<xref ref-type="bibr" rid="article-22261.r41">[41]</xref>&#x000a0;The dose&#x000a0;is oral or IV 500 mg.</p>
          </list-item>
          <list-item>
            <p><bold>Intravenous mannitol:</bold> Mannitol, an osmotic diuretic, is given intravenously to decrease the volume of aqueous humor and lower IOP rapidly. It draws fluid out of the eye, thereby reducing intraocular pressure.<xref ref-type="bibr" rid="article-22261.r42">[42]</xref>&#x000a0;The dosage is typically 1 to 2 grams per kilogram of body weight.</p>
          </list-item>
          <list-item>
            <p><bold>Topical beta-blocker:</bold> A topical beta-blocker, such as timolol 0.5%, is applied as eye drops to block aqueous humor production. Beta-blockers reduce IOP by inhibiting the beta-adrenergic receptors in the ciliary body, thereby decreasing aqueous humor production.<xref ref-type="bibr" rid="article-22261.r43">[43]</xref>&#x000a0;The dose is timolol 0.5%;&#x000a0;apply 1 drop on the affected eye.</p>
          </list-item>
          <list-item>
            <p><bold>Topical alpha 2-agonist:</bold> An alpha 2-agonist, like apraclonidine 1%, is used as eye drops to block aqueous humor production. These medications reduce the production of aqueous humor and enhance the outflow of aqueous humor through the trabecular meshwork.<xref ref-type="bibr" rid="article-22261.r44">[44]</xref>&#x000a0;The dose is&#x000a0;apraclonidine 1%;&#x000a0;apply&#x000a0;1 drop to the affected eye.</p>
          </list-item>
          <list-item>
            <p><bold>Topical pilocarpine:</bold> Pilocarpine, a miotic agent, is instilled as eye drops to increase the outflow of aqueous humor. It works by constricting the pupil and tightening the tension of the iris, which helps open the angle between the iris and cornea, facilitating aqueous humor drainage. Pilocarpine is usually administered once the intraocular pressure is below 40 mm Hg. The dose&#x000a0;is pilocarpine 1% to 2%;&#x000a0;apply 1 drop every 15 minutes for&#x000a0;2 doses once&#x000a0;IOP is below 40 mm Hg.<xref ref-type="bibr" rid="article-22261.r45">[45]</xref></p>
          </list-item>
        </list>
        <p>During the acute phase of AAC, it is crucial to closely monitor IOP to assess the effectiveness of treatment and ensure that it returns to normal values. Frequent IOP measurements are necessary to evaluate the response to therapy and make any necessary adjustments. The recommended frequency of IOP checks may vary depending on the specific situation and the response to treatment. Still, generally, it is advised to measure IOP at least every hour after the initial onset of symptoms until the IOP stabilizes.</p>
        <p>After the acute episode of AAC subsides, definitive treatment focuses on preventing future angle-closure attacks and managing the underlying anatomical risk factors. The following treatment options are commonly employed:</p>
        <p>Laser peripheral iridotomy (LPI) is the treatment of choice.<xref ref-type="bibr" rid="article-22261.r46">[46]</xref>&#x000a0;LPI involves using a laser to create a small hole in the peripheral iris, allowing for the flow of aqueous humor from the posterior chamber to the anterior chamber, bypassing the blocked angle. LPI helps to relieve pupillary block and prevent future angle-closure episodes.&#x000a0;LPI is a minimally invasive procedure performed on an outpatient basis.</p>
        <p>Surgical iridectomy is indicated when laser iridectomy cannot be&#x000a0;performed or is insufficient.<xref ref-type="bibr" rid="article-22261.r47">[47]</xref>&#x000a0;This involves surgically removing a portion of the iris to create a permanent opening and relieve the pupillary block. Surgical iridectomy is typically reserved for situations where laser treatment is not feasible or unsuccessful.</p>
        <p>Iridectomy or iridotomy relieves the pupillary block as the pressure between the posterior and anterior chamber approaches zero by allowing the flow of aqueous humor through a different route. Iridectomy/iridotomy should be as peripheral as possible and covered by the eyelid to avoid monocular diplopia through this second hole in the pupil.<xref ref-type="bibr" rid="article-22261.r48">[48]</xref></p>
        <p>Lens extraction can&#x000a0;be considered when there&#x000a0;are significant&#x000a0;anatomical risk factors. In these cases, lens extraction may be considered as a first-line treatment.<xref ref-type="bibr" rid="article-22261.r49">[49]</xref>&#x000a0;Lens extraction involves removing the crystalline lens, which can relieve the anatomical factors contributing to angle closure. This approach is often beneficial in eyes with advanced AAC.</p>
        <p>If elevated IOP persists after the acute phase of&#x000a0;AAC, treatment strategies similar to those used in open-angle glaucoma can be employed.&#x000a0;These include topical medical therapy, laser treatment, and surgical interventions.</p>
        <p>Routine ophthalmologic examinations, visual field testing, and OCT should be considered if the patient shows risks of developing elevated IOP and future glaucomatous damage.</p>
      </sec>
      <sec id="article-22261.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Numerous conditions can lead to elevated IOP, corneal haze, inflammation of the conjunctiva and the anterior segment, and similar signs and symptoms seen in patients with AAC. When evaluating a patient presenting with these manifestations, the following differential diagnosis should be considered:</p>
        <list list-type="bullet">
          <list-item>
            <p>Allergic conjunctivitis</p>
          </list-item>
          <list-item>
            <p>Bacterial conjunctivitis (pink eye)</p>
          </list-item>
          <list-item>
            <p>Viral conjunctivitis</p>
          </list-item>
          <list-item>
            <p>Keratitis</p>
          </list-item>
          <list-item>
            <p>Episcleritis or scleritis</p>
          </list-item>
          <list-item>
            <p>Eye trauma</p>
          </list-item>
          <list-item>
            <p>Chemical injury</p>
          </list-item>
          <list-item>
            <p>Corneal ulcer</p>
          </list-item>
          <list-item>
            <p>Open-angle glaucoma</p>
          </list-item>
          <list-item>
            <p>Drug-induced glaucoma</p>
          </list-item>
          <list-item>
            <p>Malignant glaucoma</p>
          </list-item>
          <list-item>
            <p>Neovascular glaucoma</p>
          </list-item>
          <list-item>
            <p>Phacomorphic glaucoma</p>
          </list-item>
          <list-item>
            <p>Senile cataract (age-related cataract)</p>
          </list-item>
          <list-item>
            <p>Lens subluxation<xref ref-type="bibr" rid="article-22261.r50">[50]</xref></p>
          </list-item>
          <list-item>
            <p>Migraine headache<xref ref-type="bibr" rid="article-22261.r51">[51]</xref></p>
          </list-item>
          <list-item>
            <p>Cluster headache</p>
          </list-item>
          <list-item>
            <p>Suprachoroidal hemorrhage</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-22261.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The prognosis of AAC is significantly influenced by early detection and prompt treatment. A study involving 116 cases of ACAG&#x000a0;found that the&#x000a0;timing&#x000a0;of presentation and the duration of&#x000a0;the acute episode&#x000a0;were crucial factors&#x000a0;in determining these patients' outcomes. High IOP&#x000a0;was found to have less impact&#x000a0;on the long-term prognosis of this condition.<xref ref-type="bibr" rid="article-22261.r52">[52]</xref></p>
      </sec>
      <sec id="article-22261.s11" sec-type="Complications">
        <title>Complications</title>
        <p>If ACAG goes undetected and&#x000a0;untreated in its&#x000a0;early stages, it can&#x000a0;result in&#x000a0;temporary vision loss or blindness.&#x000a0;The condition's progression typically involves a sequential loss of peripheral vision followed by a loss of central vision. However, in some cases, ACAG can develop into a more severe and challenging-to-treat form known as malignant glaucoma.</p>
        <p>A significant increase in IOP characterizes malignant glaucoma despite a patent iridotomy. In this condition, the eye's anterior chamber becomes flat due to a fluid imbalance, leading to further elevation of IOP. Malignant glaucoma is also called aqueous misdirection syndrome or ciliary block glaucoma. This condition is challenging to treat and progressively leads to blindness.<xref ref-type="bibr" rid="article-22261.r53">[53]</xref></p>
      </sec>
      <sec id="article-22261.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients with a history of acute angle-closure glaucoma should be advised to avoid dim lighting conditions. Dim light can cause pupils to dilate, further narrowing the iridocorneal angle.</p>
        <p>Patients with hypermetropia are at an increased risk of developing angle-closure glaucoma. This is because hypermetropia is often associated with specific anatomical predispositions that can contribute to angle closure, such as a shallow anterior chamber depth or a more anterior lens position. LPI&#x000a0;is a recommended preventative measure in individuals with AAC risk factors.<xref ref-type="bibr" rid="article-22261.r48">[48]</xref></p>
      </sec>
      <sec id="article-22261.s13" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>In patients with an AAC, an untreated opposite eye shares the same anatomic predisposing factors as the first eye.&#x000a0;The untreated eye has a 40% to 80% chance of developing an AAC glaucoma&#x000a0;within 5 to 10 years.<xref ref-type="bibr" rid="article-22261.r54">[54]</xref>&#x000a0;Therefore, it is recommended to perform LPI not only in the affected eye but also in the other eye to reduce the risk of such an attack.</p>
        <p>The presence of gender and ethnicity as predisposing factors for&#x000a0;AAC glaucoma&#x000a0;suggests&#x000a0;a genetic predisposition to the disease in specific populations. Recent large-scale studies have provided strong evidence linking&#x000a0;several genes and genetic loci&#x000a0;to primary open-angle glaucoma. However, evidence for acute angle-closure glaucoma is sparse. Only&#x000a0;1 study has identified&#x000a0;a genetic locus on chromosome 11 that can&#x000a0;contribute to the development of&#x000a0;AAC glaucoma.</p>
        <p>Research&#x000a0;has been conducted&#x000a0;to explore potential&#x000a0;therapeutic targets&#x000a0;for patients with early-onset glaucoma, focusing on molecular and cellular events&#x000a0;triggered by mutations in genes myocilin (<italic toggle="yes">MYOC</italic>), optineurin (<italic toggle="yes">OPTN</italic>), and TANK-binding kinase 1 (<italic toggle="yes">TBK1</italic>).<xref ref-type="bibr" rid="article-22261.r55">[55]</xref></p>
      </sec>
      <sec id="article-22261.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>The optimal management of acute angle-closure glaucoma&#x000a0;requires a collaborative approach involving an&#x000a0;interprofessional team comprising an ophthalmologist, a family practitioner, an ophthalmology nurse, and a pharmacist. In initial emergency management, the administration of appropriate eye drops is crucial. However, it is essential to note that this is typically a temporary measure.</p>
        <p>Following the emergency intervention, it is essential to schedule the patient for an iridectomy. Healthcare practitioners should be mindful that the contralateral eye is susceptible to AAC glaucoma. Thus, prophylactic surgery, such as laser peripheral iridotomy, is also recommended to reduce the risk in that eye.</p>
        <p>Patients with acute angle-closure glaucoma generally have favorable outcomes if timely treatment is provided. However, it is crucial to emphasize that any delay in treatment can have serious consequences, including potential damage to the optic nerve and resulting vision loss. Swift intervention is essential to alleviate intraocular pressure and preserve visual function. Therefore, prompt recognition and appropriate management are paramount to optimize the prognosis for individuals with acute angle-closure glaucoma.</p>
      </sec>
      <sec id="article-22261.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=22261&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=22261">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/eye-health/acute-angle-closure-glaucoma/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=22261">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/22261/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=22261">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-22261.s16">
        <title>References</title>
        <ref id="article-22261.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pohl</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Tarnutzer</surname>
                <given-names>AA</given-names>
              </name>
            </person-group>
            <article-title>Acute Angle-Closure Glaucoma.</article-title>
            <source>N Engl J Med</source>
            <year>2018</year>
            <month>Mar</month>
            <day>08</day>
            <volume>378</volume>
            <issue>10</issue>
            <fpage>e14</fpage>
            <pub-id pub-id-type="pmid">29514027</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22261.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nuessle</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Luebke</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Boehringer</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Reinhard</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Anton</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>[Acute angle closure : An ophthalmological emergency in the emergency room].</article-title>
            <source>Med Klin Intensivmed Notfmed</source>
            <year>2022</year>
            <month>Mar</month>
            <volume>117</volume>
            <issue>2</issue>
            <fpage>137</fpage>
            <page-range>137-143</page-range>
            <pub-id pub-id-type="pmid">33580819</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22261.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Walland</surname>
                <given-names>MJ</given-names>
              </name>
            </person-group>
            <article-title>Acute angle closure glaucoma?</article-title>
            <source>Clin Exp Ophthalmol</source>
            <year>2018</year>
            <month>Apr</month>
            <volume>46</volume>
            <issue>3</issue>
            <fpage>211</fpage>
            <page-range>211-212</page-range>
            <pub-id pub-id-type="pmid">29665201</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22261.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>N&#x000fc;ssle</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Reinhard</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>L&#x000fc;bke</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Acute Closed-Angle Glaucoma-an Ophthalmological Emergency.</article-title>
            <source>Dtsch Arztebl Int</source>
            <year>2021</year>
            <month>Nov</month>
            <day>12</day>
            <volume>118</volume>
            <issue>Forthcoming</issue>
            <fpage>771</fpage>
            <page-range>771-80</page-range>
            <pub-id pub-id-type="pmid">34551857</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22261.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brusini</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Salvetat</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Zeppieri</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>How to Measure Intraocular Pressure: An Updated Review of Various Tonometers.</article-title>
            <source>J Clin Med</source>
            <year>2021</year>
            <month>Aug</month>
            <day>27</day>
            <volume>10</volume>
            <issue>17</issue>
            <pub-id pub-id-type="pmid">34501306</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22261.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chua</surname>
                <given-names>PY</given-names>
              </name>
              <name>
                <surname>Day</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Lai</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Hall</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Tan</surname>
                <given-names>LL</given-names>
              </name>
              <name>
                <surname>Khan</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Lim</surname>
                <given-names>LT</given-names>
              </name>
              <name>
                <surname>Foot</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Foster</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Azuara-Blanco</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>The incidence of acute angle closure in Scotland: a prospective surveillance study.</article-title>
            <source>Br J Ophthalmol</source>
            <year>2018</year>
            <month>Apr</month>
            <volume>102</volume>
            <issue>4</issue>
            <fpage>539</fpage>
            <page-range>539-543</page-range>
            <pub-id pub-id-type="pmid">28794074</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22261.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wagner</surname>
                <given-names>IV</given-names>
              </name>
              <name>
                <surname>Stewart</surname>
                <given-names>MW</given-names>
              </name>
              <name>
                <surname>Dorairaj</surname>
                <given-names>SK</given-names>
              </name>
            </person-group>
            <article-title>Updates on the Diagnosis and Management of Glaucoma.</article-title>
            <source>Mayo Clin Proc Innov Qual Outcomes</source>
            <year>2022</year>
            <month>Dec</month>
            <volume>6</volume>
            <issue>6</issue>
            <fpage>618</fpage>
            <page-range>618-635</page-range>
            <pub-id pub-id-type="pmid">36405987</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22261.r8">
          <label>8</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Zeppieri</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gurnani</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <chapter-title>Applanation Tonometry</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>6</month>
            <day>11</day>
            <pub-id pub-id-type="pmid">35881737</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22261.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sun</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Dai</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Yu</surname>
                <given-names>DY</given-names>
              </name>
              <name>
                <surname>Cringle</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kong</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Jiang</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Primary angle closure glaucoma: What we know and what we don't know.</article-title>
            <source>Prog Retin Eye Res</source>
            <year>2017</year>
            <month>Mar</month>
            <volume>57</volume>
            <fpage>26</fpage>
            <page-range>26-45</page-range>
            <pub-id pub-id-type="pmid">28039061</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22261.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Weinreb</surname>
                <given-names>RN</given-names>
              </name>
              <name>
                <surname>Aung</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Medeiros</surname>
                <given-names>FA</given-names>
              </name>
            </person-group>
            <article-title>The pathophysiology and treatment of glaucoma: a review.</article-title>
            <source>JAMA</source>
            <year>2014</year>
            <month>May</month>
            <day>14</day>
            <volume>311</volume>
            <issue>18</issue>
            <fpage>1901</fpage>
            <page-range>1901-11</page-range>
            <pub-id pub-id-type="pmid">24825645</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22261.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Flores-S&#x000e1;nchez</surname>
                <given-names>BC</given-names>
              </name>
              <name>
                <surname>Tatham</surname>
                <given-names>AJ</given-names>
              </name>
            </person-group>
            <article-title>Acute angle closure glaucoma.</article-title>
            <source>Br J Hosp Med (Lond)</source>
            <year>2019</year>
            <month>Dec</month>
            <day>02</day>
            <volume>80</volume>
            <issue>12</issue>
            <fpage>C174</fpage>
            <page-range>C174-C179</page-range>
            <pub-id pub-id-type="pmid">31822188</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22261.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Marchini</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Chemello</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Berzaghi</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Zampieri</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>New findings in the diagnosis and treatment of primary angle-closure glaucoma.</article-title>
            <source>Prog Brain Res</source>
            <year>2015</year>
            <volume>221</volume>
            <fpage>191</fpage>
            <page-range>191-212</page-range>
            <pub-id pub-id-type="pmid">26518079</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22261.r13">
          <label>13</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Dave</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Zeppieri</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Meyer</surname>
                <given-names>JJ</given-names>
              </name>
            </person-group>
            <chapter-title>Chronic Closed Angle Glaucoma</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2024</year>
            <month>1</month>
            <day>25</day>
            <pub-id pub-id-type="pmid">32644524</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22261.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Man</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Chan</surname>
                <given-names>NC</given-names>
              </name>
              <name>
                <surname>Baig</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Kwong</surname>
                <given-names>YY</given-names>
              </name>
              <name>
                <surname>Leung</surname>
                <given-names>DY</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>FC</given-names>
              </name>
              <name>
                <surname>Tham</surname>
                <given-names>CC</given-names>
              </name>
            </person-group>
            <article-title>Anatomical effects of clear lens extraction by phacoemulsification versus trabeculectomy on anterior chamber drainage angle in primary angle-closure glaucoma (PACG) patients.</article-title>
            <source>Graefes Arch Clin Exp Ophthalmol</source>
            <year>2015</year>
            <month>May</month>
            <volume>253</volume>
            <issue>5</issue>
            <fpage>773</fpage>
            <page-range>773-8</page-range>
            <pub-id pub-id-type="pmid">25644619</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22261.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Liu</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ma</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Zheng</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Associated factors of acute primary angle closure glaucoma in a sub-group of Chinese people: comparison between attack eyes and normal controls.</article-title>
            <source>Sci Rep</source>
            <year>2017</year>
            <month>Nov</month>
            <day>02</day>
            <volume>7</volume>
            <issue>1</issue>
            <fpage>14885</fpage>
            <pub-id pub-id-type="pmid">29097742</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22261.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Anderson</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Jin</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Wright</surname>
                <given-names>MM</given-names>
              </name>
            </person-group>
            <article-title>The physiologic characteristics of relative pupillary block.</article-title>
            <source>Am J Ophthalmol</source>
            <year>1991</year>
            <month>Mar</month>
            <day>15</day>
            <volume>111</volume>
            <issue>3</issue>
            <fpage>344</fpage>
            <page-range>344-50</page-range>
            <pub-id pub-id-type="pmid">2000905</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22261.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Suwan</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Jiamsawad</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Supakontanasan</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Teekhasaenee</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Hidden mechanisms beyond the pupillary block in acute angle closure: ultrasound biomicroscopic study.</article-title>
            <source>Clin Exp Ophthalmol</source>
            <year>2017</year>
            <month>May</month>
            <volume>45</volume>
            <issue>4</issue>
            <fpage>366</fpage>
            <page-range>366-370</page-range>
            <pub-id pub-id-type="pmid">27770479</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22261.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Prum</surname>
                <given-names>BE</given-names>
              </name>
              <name>
                <surname>Herndon</surname>
                <given-names>LW</given-names>
              </name>
              <name>
                <surname>Moroi</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Mansberger</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Stein</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Lim</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Rosenberg</surname>
                <given-names>LF</given-names>
              </name>
              <name>
                <surname>Gedde</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>RD</given-names>
              </name>
            </person-group>
            <article-title>Primary Angle Closure Preferred Practice Pattern(&#x000ae;) Guidelines.</article-title>
            <source>Ophthalmology</source>
            <year>2016</year>
            <month>Jan</month>
            <volume>123</volume>
            <issue>1</issue>
            <fpage>P1</fpage>
            <page-range>P1-P40</page-range>
            <pub-id pub-id-type="pmid">26581557</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22261.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tham</surname>
                <given-names>YC</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>TY</given-names>
              </name>
              <name>
                <surname>Quigley</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>Aung</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Cheng</surname>
                <given-names>CY</given-names>
              </name>
            </person-group>
            <article-title>Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis.</article-title>
            <source>Ophthalmology</source>
            <year>2014</year>
            <month>Nov</month>
            <volume>121</volume>
            <issue>11</issue>
            <fpage>2081</fpage>
            <page-range>2081-90</page-range>
            <pub-id pub-id-type="pmid">24974815</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22261.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>George</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Panda</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Vijaya</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Blindness in glaucoma: primary open-angle glaucoma versus primary angle-closure glaucoma-a meta-analysis.</article-title>
            <source>Eye (Lond)</source>
            <year>2022</year>
            <month>Nov</month>
            <volume>36</volume>
            <issue>11</issue>
            <fpage>2099</fpage>
            <page-range>2099-2105</page-range>
            <pub-id pub-id-type="pmid">34645961</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22261.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Seah</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Foster</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Chew</surname>
                <given-names>PT</given-names>
              </name>
              <name>
                <surname>Jap</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Oen</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Fam</surname>
                <given-names>HB</given-names>
              </name>
              <name>
                <surname>Lim</surname>
                <given-names>AS</given-names>
              </name>
            </person-group>
            <article-title>Incidence of acute primary angle-closure glaucoma in Singapore. An island-wide survey.</article-title>
            <source>Arch Ophthalmol</source>
            <year>1997</year>
            <month>Nov</month>
            <volume>115</volume>
            <issue>11</issue>
            <fpage>1436</fpage>
            <page-range>1436-40</page-range>
            <pub-id pub-id-type="pmid">9366676</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22261.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Park</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>TW</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>BJ</given-names>
              </name>
            </person-group>
            <article-title>Nationwide Incidence of Acute Angle Closure Glaucoma in Korea from 2011 to 2015.</article-title>
            <source>J Korean Med Sci</source>
            <year>2019</year>
            <month>Dec</month>
            <day>16</day>
            <volume>34</volume>
            <issue>48</issue>
            <fpage>e306</fpage>
            <pub-id pub-id-type="pmid">31833263</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22261.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ahram</surname>
                <given-names>DF</given-names>
              </name>
              <name>
                <surname>Alward</surname>
                <given-names>WL</given-names>
              </name>
              <name>
                <surname>Kuehn</surname>
                <given-names>MH</given-names>
              </name>
            </person-group>
            <article-title>The genetic mechanisms of primary angle closure glaucoma.</article-title>
            <source>Eye (Lond)</source>
            <year>2015</year>
            <month>Oct</month>
            <volume>29</volume>
            <issue>10</issue>
            <fpage>1251</fpage>
            <page-range>1251-9</page-range>
            <pub-id pub-id-type="pmid">26206529</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22261.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jonas</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Iribarren</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Nangia</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Sinha</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pardhi</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Shukla</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Panda-Jonas</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Lens Position and Age: The Central India Eye and Medical Study.</article-title>
            <source>Invest Ophthalmol Vis Sci</source>
            <year>2015</year>
            <month>Aug</month>
            <volume>56</volume>
            <issue>9</issue>
            <fpage>5309</fpage>
            <page-range>5309-14</page-range>
            <pub-id pub-id-type="pmid">26258615</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22261.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bourne</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>Taylor</surname>
                <given-names>HR</given-names>
              </name>
              <name>
                <surname>Flaxman</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Keeffe</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Leasher</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Naidoo</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Pesudovs</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>White</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>TY</given-names>
              </name>
              <name>
                <surname>Resnikoff</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Jonas</surname>
                <given-names>JB</given-names>
              </name>
              <collab>Vision Loss Expert Group of the Global Burden of Disease Study</collab>
            </person-group>
            <article-title>Number of People Blind or Visually Impaired by Glaucoma Worldwide and in World Regions 1990 - 2010: A Meta-Analysis.</article-title>
            <source>PLoS One</source>
            <year>2016</year>
            <volume>11</volume>
            <issue>10</issue>
            <fpage>e0162229</fpage>
            <pub-id pub-id-type="pmid">27764086</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22261.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Xu</surname>
                <given-names>BY</given-names>
              </name>
              <name>
                <surname>Friedman</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Foster</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Jiang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Porporato</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Pardeshi</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Jiang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Munoz</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Aung</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>He</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Ocular Biometric Risk Factors for Progression of Primary Angle Closure Disease: The Zhongshan Angle Closure Prevention Trial.</article-title>
            <source>Ophthalmology</source>
            <year>2022</year>
            <month>Mar</month>
            <volume>129</volume>
            <issue>3</issue>
            <fpage>267</fpage>
            <page-range>267-275</page-range>
            <pub-id pub-id-type="pmid">34634364</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22261.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Neacsu</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>IMPORTANCE OF DEMOGRAPHIC RISK FACTORS FOR PRIMARY ANGLE CLOSURE.</article-title>
            <source>Rom J Ophthalmol</source>
            <year>2015</year>
            <season>Apr-Jun</season>
            <volume>59</volume>
            <issue>2</issue>
            <fpage>112</fpage>
            <page-range>112-5</page-range>
            <pub-id pub-id-type="pmid">26978873</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22261.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Samokhvalov</surname>
                <given-names>NV</given-names>
              </name>
              <name>
                <surname>Sorokin</surname>
                <given-names>EL</given-names>
              </name>
              <name>
                <surname>Marchenko</surname>
                <given-names>AN</given-names>
              </name>
              <name>
                <surname>Pashentsev</surname>
                <given-names>IE</given-names>
              </name>
            </person-group>
            <article-title>[Anatomical and morphometric features of anterior eye segment structures in hyperopia and the risk of developing primary angle-closure glaucoma].</article-title>
            <source>Vestn Oftalmol</source>
            <year>2022</year>
            <volume>138</volume>
            <issue>5</issue>
            <fpage>22</fpage>
            <page-range>22-28</page-range>
            <pub-id pub-id-type="pmid">36288414</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22261.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Foster</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Luben</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Khawaja</surname>
                <given-names>AP</given-names>
              </name>
            </person-group>
            <article-title>Association, Risk, and Causation-Examining the Role of Systemic Medications in the Onset of Acute Angle-Closure Episodes.</article-title>
            <source>JAMA Ophthalmol</source>
            <year>2022</year>
            <month>Nov</month>
            <day>01</day>
            <volume>140</volume>
            <issue>11</issue>
            <fpage>1064</fpage>
            <page-range>1064-1065</page-range>
            <pub-id pub-id-type="pmid">36136324</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22261.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Na</surname>
                <given-names>KI</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>SP</given-names>
              </name>
            </person-group>
            <article-title>Association of Drugs With Acute Angle Closure.</article-title>
            <source>JAMA Ophthalmol</source>
            <year>2022</year>
            <month>Nov</month>
            <day>01</day>
            <volume>140</volume>
            <issue>11</issue>
            <fpage>1055</fpage>
            <page-range>1055-1063</page-range>
            <pub-id pub-id-type="pmid">36136326</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22261.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lai</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Choy</surname>
                <given-names>BN</given-names>
              </name>
              <name>
                <surname>Shum</surname>
                <given-names>JW</given-names>
              </name>
            </person-group>
            <article-title>Management of Primary Angle-Closure Glaucoma.</article-title>
            <source>Asia Pac J Ophthalmol (Phila)</source>
            <year>2016</year>
            <season>Jan-Feb</season>
            <volume>5</volume>
            <issue>1</issue>
            <fpage>59</fpage>
            <page-range>59-62</page-range>
            <pub-id pub-id-type="pmid">26886121</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22261.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Parivadhini</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lingam</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Management of Secondary Angle Closure Glaucoma.</article-title>
            <source>J Curr Glaucoma Pract</source>
            <year>2014</year>
            <season>Jan-Apr</season>
            <volume>8</volume>
            <issue>1</issue>
            <fpage>25</fpage>
            <page-range>25-32</page-range>
            <pub-id pub-id-type="pmid">26997804</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22261.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <article-title>European Glaucoma Society Terminology and Guidelines for Glaucoma, 5th Edition.</article-title>
            <source>Br J Ophthalmol</source>
            <year>2021</year>
            <month>Jun</month>
            <volume>105</volume>
            <issue>Suppl 1</issue>
            <fpage>1</fpage>
            <page-range>1-169</page-range>
            <pub-id pub-id-type="pmid">34675001</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22261.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Collignon</surname>
                <given-names>NJ</given-names>
              </name>
            </person-group>
            <article-title>Emergencies in glaucoma: a review.</article-title>
            <source>Bull Soc Belge Ophtalmol</source>
            <year>2005</year>
            <issue>296</issue>
            <fpage>71</fpage>
            <page-range>71-81</page-range>
            <pub-id pub-id-type="pmid">16050422</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22261.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cai</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>YL</given-names>
              </name>
              <name>
                <surname>Cao</surname>
                <given-names>YH</given-names>
              </name>
              <name>
                <surname>Babenko</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>X</given-names>
              </name>
            </person-group>
            <article-title>Numerical study of aqueous humor flow and iris deformation with pupillary block and the efficacy of laser peripheral iridotomy.</article-title>
            <source>Clin Biomech (Bristol, Avon)</source>
            <year>2022</year>
            <month>Feb</month>
            <volume>92</volume>
            <fpage>105579</fpage>
            <pub-id pub-id-type="pmid">35085976</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22261.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Junqueira</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Prado</surname>
                <given-names>VG</given-names>
              </name>
              <name>
                <surname>Lopes</surname>
                <given-names>FS</given-names>
              </name>
              <name>
                <surname>Biteli</surname>
                <given-names>LG</given-names>
              </name>
              <name>
                <surname>Dorairaj</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Prata</surname>
                <given-names>TS</given-names>
              </name>
            </person-group>
            <article-title>Non-pupillary block angle-closure mechanisms: a comprehensive analysis of their prevalence and treatment outcomes.</article-title>
            <source>Arq Bras Oftalmol</source>
            <year>2014</year>
            <season>Nov-Dec</season>
            <volume>77</volume>
            <issue>6</issue>
            <fpage>360</fpage>
            <page-range>360-3</page-range>
            <pub-id pub-id-type="pmid">25627181</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22261.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Watkinson</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Assessment and management of patients with acute red eye.</article-title>
            <source>Nurs Older People</source>
            <year>2013</year>
            <month>Jun</month>
            <volume>25</volume>
            <issue>5</issue>
            <fpage>27</fpage>
            <page-range>27-34; quiz 35</page-range>
            <pub-id pub-id-type="pmid">23914708</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22261.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Garala</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Bansal</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Acute Secondary Optic Neuropathy as a Complication of a Single Episode of Acutely Raised Intraocular Pressure: A Case Series.</article-title>
            <source>J Glaucoma</source>
            <year>2019</year>
            <month>Jan</month>
            <volume>28</volume>
            <issue>1</issue>
            <fpage>e10</fpage>
            <page-range>e10-e13</page-range>
            <pub-id pub-id-type="pmid">30234746</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22261.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shaw</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Burnett</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Eke</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>A simple technique for indirect gonioscopy for patients who cannot be examined at the slit lamp.</article-title>
            <source>Br J Ophthalmol</source>
            <year>2006</year>
            <month>Sep</month>
            <volume>90</volume>
            <issue>9</issue>
            <fpage>1209</fpage>
            <pub-id pub-id-type="pmid">16929072</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22261.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Anwar</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Turalba</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>An Overview of Treatment Methods for Primary Angle Closure.</article-title>
            <source>Semin Ophthalmol</source>
            <year>2017</year>
            <volume>32</volume>
            <issue>1</issue>
            <fpage>82</fpage>
            <page-range>82-85</page-range>
            <pub-id pub-id-type="pmid">27686782</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22261.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>&#x000d6;zmen</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>&#x000d6;zkan Aksoy</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>&#x000c7;ak&#x00131;r</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Alag&#x000f6;z</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Acute angle-closure glaucoma concurrent with COVID 19 infection; case report.</article-title>
            <source>Eur J Ophthalmol</source>
            <year>2023</year>
            <month>Jul</month>
            <volume>33</volume>
            <issue>4</issue>
            <fpage>NP42</fpage>
            <page-range>NP42-NP45</page-range>
            <pub-id pub-id-type="pmid">35815850</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22261.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Grewal</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Goldstein</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Khatana</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Tanna</surname>
                <given-names>AP</given-names>
              </name>
            </person-group>
            <article-title>Bilateral angle closure following use of a weight loss combination agent containing topiramate.</article-title>
            <source>J Glaucoma</source>
            <year>2015</year>
            <season>Jun-Jul</season>
            <volume>24</volume>
            <issue>5</issue>
            <fpage>e132</fpage>
            <page-range>e132-6</page-range>
            <pub-id pub-id-type="pmid">25304279</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22261.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wright</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Tawfik</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Waisbourd</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Katz</surname>
                <given-names>LJ</given-names>
              </name>
            </person-group>
            <article-title>Primary angle-closure glaucoma: an update.</article-title>
            <source>Acta Ophthalmol</source>
            <year>2016</year>
            <month>May</month>
            <volume>94</volume>
            <issue>3</issue>
            <fpage>217</fpage>
            <page-range>217-25</page-range>
            <pub-id pub-id-type="pmid">26119516</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22261.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jonas</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Aung</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Bourne</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>Bron</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Ritch</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Panda-Jonas</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Glaucoma.</article-title>
            <source>Lancet</source>
            <year>2017</year>
            <month>Nov</month>
            <day>11</day>
            <volume>390</volume>
            <issue>10108</issue>
            <fpage>2183</fpage>
            <page-range>2183-2193</page-range>
            <pub-id pub-id-type="pmid">28577860</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22261.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yen</surname>
                <given-names>CY</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Tseng</surname>
                <given-names>PC</given-names>
              </name>
            </person-group>
            <article-title>Role of pilocarpine use following laser peripheral iridotomy in eyes with refractory acute angle closure glaucoma: A case report and literature review.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>2022</year>
            <month>Jul</month>
            <day>08</day>
            <volume>101</volume>
            <issue>27</issue>
            <fpage>e29245</fpage>
            <pub-id pub-id-type="pmid">35801778</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22261.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chan</surname>
                <given-names>PP</given-names>
              </name>
              <name>
                <surname>Pang</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Tham</surname>
                <given-names>CC</given-names>
              </name>
            </person-group>
            <article-title>Acute primary angle closure-treatment strategies, evidences and economical considerations.</article-title>
            <source>Eye (Lond)</source>
            <year>2019</year>
            <month>Jan</month>
            <volume>33</volume>
            <issue>1</issue>
            <fpage>110</fpage>
            <page-range>110-119</page-range>
            <pub-id pub-id-type="pmid">30467424</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22261.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nguyen</surname>
                <given-names>HX</given-names>
              </name>
              <name>
                <surname>Nguyen</surname>
                <given-names>ND</given-names>
              </name>
              <name>
                <surname>Nguyen</surname>
                <given-names>HT</given-names>
              </name>
              <name>
                <surname>Fan</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>Vo</surname>
                <given-names>HT</given-names>
              </name>
              <name>
                <surname>Nguyen</surname>
                <given-names>CV</given-names>
              </name>
              <name>
                <surname>Pham</surname>
                <given-names>HTT</given-names>
              </name>
              <name>
                <surname>Aung</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Nguyen</surname>
                <given-names>HDTN</given-names>
              </name>
              <name>
                <surname>Do</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Comparing combined laser iridoplasty and surgical iridectomy with trabeculectomy in treatment of refractory acute primary angle closure without significant cataract: a randomized controlled trial.</article-title>
            <source>Eye (Lond)</source>
            <year>2023</year>
            <month>Jul</month>
            <volume>37</volume>
            <issue>10</issue>
            <fpage>2139</fpage>
            <page-range>2139-2144</page-range>
            <pub-id pub-id-type="pmid">36402857</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22261.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>He</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Jiang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Munoz</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Aung</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Foster</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Friedman</surname>
                <given-names>DS</given-names>
              </name>
            </person-group>
            <article-title>Laser peripheral iridotomy for the prevention of angle closure: a single-centre, randomised controlled trial.</article-title>
            <source>Lancet</source>
            <year>2019</year>
            <month>Apr</month>
            <day>20</day>
            <volume>393</volume>
            <issue>10181</issue>
            <fpage>1609</fpage>
            <page-range>1609-1618</page-range>
            <pub-id pub-id-type="pmid">30878226</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22261.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tanner</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Gazzard</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Nolan</surname>
                <given-names>WP</given-names>
              </name>
              <name>
                <surname>Foster</surname>
                <given-names>PJ</given-names>
              </name>
            </person-group>
            <article-title>Has the EAGLE landed for the use of clear lens extraction in angle-closure glaucoma? And how should primary angle-closure suspects be treated?</article-title>
            <source>Eye (Lond)</source>
            <year>2020</year>
            <month>Jan</month>
            <volume>34</volume>
            <issue>1</issue>
            <fpage>40</fpage>
            <page-range>40-50</page-range>
            <pub-id pub-id-type="pmid">31649349</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22261.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Xing</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Tian</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Lv</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Biometric indicators of eyes with occult lens subluxation inducing secondary acute angle closure.</article-title>
            <source>BMC Ophthalmol</source>
            <year>2020</year>
            <month>Mar</month>
            <day>05</day>
            <volume>20</volume>
            <issue>1</issue>
            <fpage>87</fpage>
            <pub-id pub-id-type="pmid">32138781</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22261.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Renton</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Bastawrous</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Acute Angle Closure Glaucoma (AACG): an important differential diagnosis for acute severe headache.</article-title>
            <source>Acute Med</source>
            <year>2011</year>
            <volume>10</volume>
            <issue>2</issue>
            <fpage>77</fpage>
            <page-range>77-8</page-range>
            <pub-id pub-id-type="pmid">22041605</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22261.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>David</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Tessler</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Yassur</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Long-term outcome of primary acute angle-closure glaucoma.</article-title>
            <source>Br J Ophthalmol</source>
            <year>1985</year>
            <month>Apr</month>
            <volume>69</volume>
            <issue>4</issue>
            <fpage>261</fpage>
            <page-range>261-2</page-range>
            <pub-id pub-id-type="pmid">3994941</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22261.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shahid</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Salmon</surname>
                <given-names>JF</given-names>
              </name>
            </person-group>
            <article-title>Malignant glaucoma: a review of the modern literature.</article-title>
            <source>J Ophthalmol</source>
            <year>2012</year>
            <volume>2012</volume>
            <fpage>852659</fpage>
            <pub-id pub-id-type="pmid">22545204</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22261.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Atalay</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Nongpiur</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Baskaran</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Perera</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Aung</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Biometric Factors Associated With Acute Primary Angle Closure: Comparison of the Affected and Fellow Eye.</article-title>
            <source>Invest Ophthalmol Vis Sci</source>
            <year>2016</year>
            <month>Oct</month>
            <day>01</day>
            <volume>57</volume>
            <issue>13</issue>
            <fpage>5320</fpage>
            <page-range>5320-5325</page-range>
            <pub-id pub-id-type="pmid">27727395</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22261.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wiggs</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Pasquale</surname>
                <given-names>LR</given-names>
              </name>
            </person-group>
            <article-title>Genetics of glaucoma.</article-title>
            <source>Hum Mol Genet</source>
            <year>2017</year>
            <month>Aug</month>
            <day>01</day>
            <volume>26</volume>
            <issue>R1</issue>
            <fpage>R21</fpage>
            <page-range>R21-R27</page-range>
            <pub-id pub-id-type="pmid">28505344</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
